|
|||||
|
|
| 加入WTO与我国医药企业发展对策研究 | |
| 引用本文： | 程艳霞,方勇,李秉桥. 加入WTO与我国医药企业发展对策研究[J]. 武汉理工大学学报(社会科学版), 2002, 15(2): 158-161 |
| 作者姓名： | 程艳霞 方勇 李秉桥 |
| 作者单位： | 武汉理工大学,管理学院,湖北,武汉,430070 |
| 摘 要： | 医药对人类生活的巨大影响使得其行业的高增长和高收益特性非常突出。中国加入 WTO后对医药产业必将产生深远的影响。文章分析了我国医药行业的现状 ,以及中国加入 WTO后对医药行业的影响 ,在此基础上提出了医药企业应对的具体措施 :即实施并购重组 ,推行技术创新 ,完善营销渠道 ,推进药品电子商务。 |
| 关 键 词： | WTO 医药企业 发展 |
| 文章编号： | 1671-6477(2002)02-0158-04 |
| 修稿时间： | 2001-12-28 |
On the Countermeasures of the Development of Chinese Medicine Enterprises after China''s Entering WTO |
|
| Cheng Yanxia Fang Yong Li Bingqiao. On the Countermeasures of the Development of Chinese Medicine Enterprises after China''s Entering WTO[J]. Journal of Wuhan University of Technology(Social Science Edition), 2002, 15(2): 158-161 | |
| Authors: | Cheng Yanxia Fang Yong Li Bingqiao |
| Abstract: | Medicine industry is notable for its high increase rate and high yield. China's entering WTO must affect Chinese medicine industry greatly. The status quo of medicine enterprises in China and the influences of China's entering WTO are studied. On the basis of the analysis, the paper mentions the measures for medicine enterprises to reply to the requirements of WTO, i.e. Acquisition & Mergers, technology innovation, perfecting marketing channels, and medicine e-commerce. |
| Keywords: | WTO medicine enterprise development |
| 本文献已被 CNKI 万方数据 等数据库收录！ | |